Wird geladen...
What can we learn from drug marketing efficiency?
The time it takes new drugs to penetrate the market is shrinking. David Kao suggests how drug companies’ techniques could be used to improve safety surveillance systems
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group Ltd.
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3230247/ https://ncbi.nlm.nih.gov/pubmed/19050331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.a2591 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|